GreenLight SPAC Presentation Deck

Plant health revenue - business plan ($ in millions) Target gross margin of 75-90%¹ for 2025 and beyond GLB Product Revenue R&D Collab. Revenue Platform Mfg. Revenue $0.0 2021E 0 $18.9 $0.6 2022E 0 $5.2 2023E Products in market 1 1. Target gross margin is for products GreenLight distributes directly; gross margin may differ for products GreenLight chooses to partner Investor Presentation | © 2021 GreenLight Biosciences. All rights reserved. GreenLight confidential. $119.7 2024E 2 2025E 7 $320.7 2026E 8 $489.3 2027E 8 PLANT HEALTH 38

View entire presentation